These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7829909)

  • 21. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evolution of susceptibilities of Campylobacter jejuni isolated from diarrhoeal cases to fluoroquinolones in Tokyo].
    Tadano K; Shingaki M; Saito K; Takahashi M; Kai A; Yanagawa Y; Itoh T; Ohta K; Kudoh Y
    Kansenshogaku Zasshi; 1996 Dec; 70(12):1227-33. PubMed ID: 9011115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
    Le Noc P; Croizé J; Le Noc D
    Pathol Biol (Paris); 1993 Apr; 41(4):294-301. PubMed ID: 8233625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens.
    Jones K; Felmingham D; Ridgway G
    Drugs Exp Clin Res; 1988; 14(10):613-5. PubMed ID: 2854515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sensitivity of enteropathogenic bacteria to furazolidone].
    Llovet T; Sánchez F; Mirelis B; Prats G
    Enferm Infecc Microbiol Clin; 1990; 8(7):449-52. PubMed ID: 2152485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetic, bacteriological and clinical studies in the pediatric field on norfloxacin].
    Nakazawa S; Niino K; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Nakanishi Y
    Jpn J Antibiot; 1990 May; 43(5):799-807. PubMed ID: 2391751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacteriological studies of travellar's diarrhoea. 5) Analysis of enteropathogenic bacteria at Osaka Airport Quarantine Station from January 1992 through September 3rd, 1994].
    Ueda Y; Suzuki N; Mori H; Miyagi K; Noda K; Hirose H; Takegaki Y; Hashimoto S; Oosumi Y; Miyata Y; Taguchi M; Ishibashi M; Honda T
    Kansenshogaku Zasshi; 1996 Jan; 70(1):29-41. PubMed ID: 8822051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
    Vanhoof R; Hubrechts JM; Roebben E; Nyssen HJ; Nulens E; Leger J; De Schepper N
    Infection; 1986; 14(6):294-8. PubMed ID: 3546145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
    Rolston K; Ho DH; LeBlanc B; Bodey GP
    Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of azithromycin against bacterial enteric pathogens.
    Gordillo ME; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1993 May; 37(5):1203-5. PubMed ID: 8390813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacteriological studies of traveller's diarrhoea (6). Analysis of enteropathogenic bacteria at Kansai Airport Quarantine Station from September 4th, 1994 through December 1996].
    Ueda Y; Suzuki N; Furukawa T; Takegaki Y; Takahashi N; Miyagi K; Noda K; Hirose H; Hashimoto S; Miyamoto H; Yano S; Miyata Y; Taguchi M; Ishibashi M; Honda T
    Kansenshogaku Zasshi; 1999 Feb; 73(2):110-21. PubMed ID: 10213987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
    Body BA; Fromtling RA; Shadomy S; Shadomy HJ
    Eur J Clin Microbiol; 1983 Jun; 2(3):230-4. PubMed ID: 6224678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
    Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of bacterial enteropathogens among hospitalized diarrhea patients from Orissa, India.
    Samal SK; Khuntia HK; Nanda PK; Satapathy CS; Nayak SR; Sarangi AK; Sahoo N; Pattnaik SK; Chhotray GP; Pal BB
    Jpn J Infect Dis; 2008 Sep; 61(5):350-5. PubMed ID: 18806340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bacteriological study of traveller's diarrhoea. 4) Isolation of enteropathogenic bacteria from patients with traveller's diarrhoea at Osaka Airport Quarantine Station during 1984-1991].
    Yoshida A; Noda K; Omura K; Miyagi K; Mori H; Suzuki N; Takai S; Matsumoto Y; Hayashi K; Miyata Y
    Kansenshogaku Zasshi; 1992 Oct; 66(10):1422-35. PubMed ID: 1293222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.